Liu, P. C. C., Koblish, H., Wu, L., Bowman, K., Diamond, S., DiMatteo, D., . . . Ruggeri, B. (2020). INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models. PLoS ONE, 15(4), 1. https://doi.org/10.1371/journal.pone.0231877
Chicago Style (17th ed.) CitationLiu, Phillip C. C., et al. "INCB054828 (pemigatinib), a Potent and Selective Inhibitor of Fibroblast Growth Factor Receptors 1, 2, and 3, Displays Activity Against Genetically Defined Tumor Models." PLoS ONE 15, no. 4 (2020): 1. https://doi.org/10.1371/journal.pone.0231877.
MLA (9th ed.) CitationLiu, Phillip C. C., et al. "INCB054828 (pemigatinib), a Potent and Selective Inhibitor of Fibroblast Growth Factor Receptors 1, 2, and 3, Displays Activity Against Genetically Defined Tumor Models." PLoS ONE, vol. 15, no. 4, 2020, p. 1, https://doi.org/10.1371/journal.pone.0231877.